Y-Intercept (HK)’s Taysha Gene Therapies TSHA Stock Holding History

Y-Intercept (HK)’s Portfolio TSHA Stock Details TSHA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,486	Closed	-$51.3K	–	2174
2026 Q1	$51.3K	Buy	+11,486	New	+$53.4K	﹤0.01%	1480
2025 Q2	–	Sell	-83,864	Closed	-$117K	–	2022
2025 Q1	$117K	Buy	+83,864	New	+$140K	0.01%	1103
2024 Q2	–	Sell	-97,054	Closed	-$279K	–	1926
2024 Q1	$279K	Buy	+97,054	New	+$202K	0.02%	988

Other funds holding TSHA

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return